Characterization of seven novel mutations causing factor XI deficiency

Haematologica

Volumn 92, Issue 10, 2007, Pages 1375-1380

  Zucker, Michal ^a   Zivelin, Ariella ^a   Landau, Meytal ^a   Salomon, Ophira ^a   Kenet, Gili ^a   Bauduer, Frederic ^b   Samama, Michel ^c   Conard, Jacqueline ^c   Denninger, Marie Hélène ^d   Hani, Abu Samra ^e   Berruyer, Micheline ^f   Feinstein, Donald ^g   Seligsohn, Uri ^a,h  

^a TEL AVIV UNIVERSITY   (Israel)

^b CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^c HÔTEL DIEU   (France)

^d BEAUJON HOSPITAL   (France)

^e MACCABI HEALTHCARE SERVICES   (Israel)

^f HOSPICES CIVILS DE LYON   (France)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h SHEBA MEDICAL CENTER   (Israel)

Author keywords

Factor 11 gene; Factor XI; Factor XI deficiency

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CELL SECRETION; CLINICAL ARTICLE; DIMERIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNOBLOTTING; KIDNEY CELL; LABORATORY TEST; MALE; MISSENSE MUTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE; CHILD; CHILD, PRESCHOOL; CRICETINAE; DIMERIZATION; FACTOR XI; FACTOR XI DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; MUTATION; PROTEIN STRUCTURE, QUATERNARY;

EID: 36349020848     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11526     Document Type: Article

References (23)

1. Meijers JCM, Mulvihill ER, Davie EW, Chung DW. Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry 1992; 31:4680-4.
2. Seligsohn U. Factor XI deficiency. Thromb Haemost 1993;70:68-71.
3. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991;325:153-8.
4. Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995;85:429-32.
5. Asakai R, Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci USA 1989;86: 7667-71.
6. Peretz H, Zivelin A, Usher S, Seligsohn U. A 14-bp deletion (coclon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency. Hum Mutat 1996;8:77-8.
7. Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002;99:2448-54.
8. Imanaka Y, Lal K, Nishimura T, Bolton-Maggs PH, Tuddenham EG, Mcvey JH. Identification of two novel mutations in non-Jewish factor XI deficiency. Br J Haematol 1995;90:916-20.
9. Bolton-Maggs PH, Peretz H, Butler R, Mountford R, Keeney S, Zacharski L, et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004; 2:918-24.
10. Saunders RE, O'Connell NM, Lee CA, Perry DJ, Perkins SJ. Factor XI deficiency database: an interactive web database of mutations, phenotypes and structural analysis tools. Hum Mutat 2005;26:192-8.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
12. Papagrigoriou E, McEwan PA, Walsh PN, Emsley J. Crystal structure of the factor XI zymogen reveals a pathway for transactivation. Nat Struct Mol Biol 2006;13:557-8.
13. Jin L, Pandey P, Babine RE, Gorga JC, Seidl KJ, Gelfand E, et al. Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions. J Biol Chem 2005;280:4704-12.
14. Sridharan S, Nicholls A, Honig, B. A new vertex algorithm to calculate solvent accessible surface area. Biophys J 1992;61:A174.
15. Landau M, Mayrose I, Rosenberg Y, Glaser F, Martz E, Pupko T, et al. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res 2005;33:W299-302.
16. Bairoch A, Apweiler R. The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999. Nucleic Acids Res 1999;27:49-54.
17. Bairoch A, Apweiler R, Wu CH, Barker WC, Boeckmann B, Ferro S, et al. The Universal Protein Resource (UniProt). Nucleic Acids Res 2005;33:D154-9.
18. Mitchell M, Mountford R, Buler R, Alhaq A, Dai L, Savidge G, et al. Spectrum of FXI (F11) mutations in the UK population - 116 index cases and 140 mutations. Hum Mutat 2006; 27:829-35.
19. Quelin F, Mathonnet F, PotentiniEsnault C, Trigui N, Peynet J, Bastenaire B, et al. Identification of five novel mutations in the factor XI gene (F11) of patients with factor XI deficiency. Blood Coagul Fibrinolysis 2006;17:69-73.
20. Kravtsov DV, Monahan PE, Gailani D. A classification system for cross-reactive material-negative factor XI deficiency. Blood 2005;105:4671-3.
21. Pugh RE, McVey JH, Tuddenham EG, Hancock JF. Six point mutations that cause factor XI deficiency. Blood 1995;85:1509-16.
22. Ventura C, Santos AIM, Tavares A, Gago T, Lavinha J, McVey JH, et al. Molecular genetic analysis of factor XI deficiency: Identification of five novel gene alterations and the origin of type II mutation in Portuguese families. Thromb Haemost 2000;84:833-40.
23. Meijers JCM, Davie EW, Chung DW. Expression of human blood coagulation factor XI: characterization or the defect in factor XI type III deficiency. Blood 1992;79:1435-40.